Molecular pathology of tumor metastasis I. Predictive pathology

Pathology and Oncology Research

Volumn 7, Issue 3, 2001, Pages 217-230

  Tímár, József ^a,b   Csuka, Orsolya ^a   Orosz, Zsolt ^a   Jeney, András ^b   Kopper, László ^b  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Breast cancer; Colon cancer; Extracellular matrix interaction; Lung cancer; Malignant melanoma; Metastatic cascade; Metastatic phenotype; Prostate cancer

Indexed keywords

FEMALE; HUMAN; MALE; METASTASIS; NEOPLASM; PATHOLOGY; REVIEW;

FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASMS;

EID: 0035228784     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032353     Document Type: Article

References (5)

1. Adachi M, Taki T, Haung C, et al: Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J Clin Oncol 16:1060-1067, 1998.
2. Batch ChM, Reintgen DS, Kirkwood JM, et al: Cutaneous melanoma. In: (DeVita, VT, Hellman S, Rosenberg SA (eds)): Principles & Practice of Oncology, Fifth Edition, Lippincott-Raven Publ. Philadelphia, Vol.1. 1947-94, 1997.
3. Bánkfalvi A, Terpe HJ, Breukelmann D et al: Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology 33:107-116, 1998.
4. Barnes DM, Gillett CE: Cyclin D1 in breast cancer. Breast Cancer Res Treat 52:1-15, 1998.
5. Bellahcene A, Albert V Pollina L, et al: Ectopic expression of bone sialoprotein in human tyroid cancer. Thyroid 8:637-641, 1998.